Drug Shortage Report for HAVRIX 720 JUNIOR

Last updated on 2018-12-21 History
Report ID 45127
Drug Identification Number 02231056
Brand name HAVRIX 720 JUNIOR
Common or Proper name hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 720UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's (prefilled syringe / seringue préremplie)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-04-04
Estimated end date 2019-01-04
Actual end date 2018-12-20
Shortage status Resolved
Updated date 2018-12-21
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-04-06 English Compare
v2 2018-04-06 French Compare
v3 2018-05-09 English Compare
v4 2018-05-09 French Compare
v5 2018-05-31 English Compare
v6 2018-05-31 French Compare
v7 2018-06-13 English Compare
v8 2018-06-13 French Compare
v9 2018-09-13 English Compare
v10 2018-09-13 French Compare
v11 2018-12-03 English Compare
v12 2018-12-03 French Compare
v13 2018-12-11 English Compare
v14 2018-12-11 French Compare
v15 2018-12-20 English Compare
v16 2018-12-20 French Compare
v17 2018-12-21 English Compare

Showing 1 to 17 of 17